Literature DB >> 15029470

Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination.

J A Araujo1, A D F Chan, L L Winka, P A Seymour, N W Milgram.   

Abstract

RATIONALE: The cholinergic system is linked extensively to memory, but its exact role remains controversial. In particular, scopolamine-induced impairment in rodents is not task specific, which may be due to difficulty in developing rodent protocols to assess deficits in recent memory, in which the remembered event is brief and distinct, and/or to non-specific behavioral impairment.
OBJECTIVES: The present study sought to determine whether scopolamine-induced deficits in recent memory, using a working memory task, could be dose-specifically dissociated from deficits in associative memory in dogs.
METHODS: A Latin-square design was used to determine the effect of scopolamine (5, 10 and 15 microg/kg; SC) on a variable delayed-non-matching-to-position (DNMP) task, which assesses visuospatial working memory. Subsequently, the minimal effective dose (15 microg/kg; SC) was administered prior to testing on a landmark discrimination task, which provides a measure of allocentric spatial ability, a black-white discrimination task, an oddity discrimination task and tests of exploratory behavior. We also investigated the effects of a 30 microg/kg dose (SC) on tests of oddity discrimination and behavioral activity.
RESULTS: A 15 microg/kg dose produced significant impairment on the DNMP task, but did not affect performance of any discrimination task and did not alter behavior on tests of open field or curiosity. A 30 microg/kg dose caused disruption on discrimination performance and on open field measures.
CONCLUSIONS: Working memory performance is most sensitive to scopolamine-induced impairment and can be dissociated from scopolamine-induced deficits in discrimination performance and non-cognitive behaviors. The present results indicate that scopolamine-induced impairments of working memory in the dog can serve as a model of age-related cholinergic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029470     DOI: 10.1007/s00213-004-1777-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

2.  Necropsy evidence of central cholinergic deficits in senile dementia.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

3.  Effects of aging and dementia upon recent visuospatial memory.

Authors:  C Flicker; R T Bartus; T H Crook; S H Ferris
Journal:  Neurobiol Aging       Date:  1984       Impact factor: 4.673

4.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

5.  Scopolamine differentially affects memory of 8- and 16-month-old rats in the double Y-maze.

Authors:  S L Biggan; J L Ingles; R J Beninger
Journal:  Neurobiol Aging       Date:  1996 Jan-Feb       Impact factor: 4.673

6.  Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus.

Authors:  A Mathur; A Shandarin; S R LaViolette; J Parker; J S Yeomans
Journal:  Brain Res       Date:  1997-11-14       Impact factor: 3.252

Review 7.  Acetylcholine: a neurotransmitter for learning and memory?

Authors:  A Blokland
Journal:  Brain Res Brain Res Rev       Date:  1995-11

8.  Scopolamine does not disrupt spatial working memory in rats.

Authors:  P R Godding; J R Rush; W W Beatty
Journal:  Pharmacol Biochem Behav       Date:  1982-06       Impact factor: 3.533

9.  Spatial learning and memory as a function of age in the dog.

Authors:  E Head; R Mehta; J Hartley; M Kameka; B J Cummings; C W Cotman; W W Ruehl; N W Milgram
Journal:  Behav Neurosci       Date:  1995-10       Impact factor: 1.912

10.  Dietary enrichment counteracts age-associated cognitive dysfunction in canines.

Authors:  N W Milgram; S C Zicker; E Head; B A Muggenburg; H Murphey; C J Ikeda-Douglas; C W Cotman
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

View more
  11 in total

1.  Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine.

Authors:  Joseph A Araujo; Gary M Landsberg; Norton W Milgram; Alda Miolo
Journal:  Can Vet J       Date:  2008-04       Impact factor: 1.008

2.  Brain Network Activation (BNA) reveals scopolamine-induced impairment of visual working memory.

Authors:  Amit Reches; Naama Levy-Cooperman; Ilan Laufer; Revital Shani-Hershkovitch; Keren Ziv; Dani Kerem; Noga Gal; Yaki Stern; Guy Cukierman; Myroslava K Romach; Edward M Sellers; Amir B Geva
Journal:  J Mol Neurosci       Date:  2014-02-18       Impact factor: 3.444

Review 3.  What do dogs (Canis familiaris) see? A review of vision in dogs and implications for cognition research.

Authors:  Sarah-Elizabeth Byosiere; Philippe A Chouinard; Tiffani J Howell; Pauleen C Bennett
Journal:  Psychon Bull Rev       Date:  2018-10

4.  Response to stimulus relations by a dog (Canis lupus familiaris).

Authors:  K Marinka Gadzichowski; Kelly Kapalka; Robert Pasnak
Journal:  Learn Behav       Date:  2016-09       Impact factor: 1.986

5.  Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.

Authors:  Joseph A Araujo; Nigel H Greig; Donald K Ingram; Johan Sandin; Christina de Rivera; Norton W Milgram
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.

Authors:  Marieke Liem-Moolenaar; Peter de Boer; Maarten Timmers; Rik C Schoemaker; J G Coen van Hasselt; Stephan Schmidt; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

7.  Individual recognition and long-term memory of inanimate interactive agents and humans in dogs.

Authors:  Judit Abdai; Dalma Bartus; Sylvain Kraus; Zsuzsanna Gedai; Beatrix Laczi; Ádám Miklósi
Journal:  Anim Cogn       Date:  2022-05-05       Impact factor: 3.084

8.  Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats.

Authors:  Kirti S Kulkarni; S B Kasture; S A Mengi
Journal:  Indian J Pharmacol       Date:  2010-06       Impact factor: 1.200

Review 9.  Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

Authors:  Hyojin Jeon; Jinglu Ai; Mohamed Sabri; Asma Tariq; Xueyuan Shang; Gang Chen; R Loch Macdonald
Journal:  BMC Neurosci       Date:  2009-08-25       Impact factor: 3.288

10.  Learning, memory and exploratory similarities in genetically identical cloned dogs.

Authors:  Chi Won Shin; Geon A Kim; Won Jun Park; Kwan Yong Park; Jeong Min Jeon; Hyun Ju Oh; Min Jung Kim; Byeong Chun Lee
Journal:  J Vet Sci       Date:  2016-12-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.